American Century Companies Inc. Increases Stock Position in Humana Inc. (NYSE:HUM)

American Century Companies Inc. boosted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 8.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,655 shares of the insurance provider's stock after acquiring an additional 1,027 shares during the quarter. American Century Companies Inc.'s holdings in Humana were worth $3,211,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Pzena Investment Management LLC grew its position in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares during the last quarter. Boston Partners boosted its holdings in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after acquiring an additional 893,637 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after acquiring an additional 65,735 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Humana by 1.7% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 330,906 shares of the insurance provider's stock worth $83,954,000 after acquiring an additional 5,497 shares during the period. Finally, Retirement Systems of Alabama raised its holdings in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after purchasing an additional 192,801 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Humana Trading Up 1.6 %

NYSE HUM traded up $4.72 during mid-day trading on Friday, reaching $294.97. 1,674,634 shares of the stock were exchanged, compared to its average volume of 1,751,127. The business's fifty day simple moving average is $265.55 and its 200 day simple moving average is $270.65. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $35.60 billion, a PE ratio of 29.65, a PEG ratio of 2.05 and a beta of 0.62. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HUM. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Barclays lifted their price target on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research note on Friday. Truist Financial increased their price objective on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research report on Friday. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Humana presently has a consensus rating of "Hold" and an average target price of $288.60.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.